| Moderated By: brk -- (Not Moderated) -- Started: 6/16/2000 1:46:00 AM Revision History |
IPO soon....some Immunex people driving the ship
Dendreon Corporation, based in Seattle, Washington, discovers and develops immunologically based therapeutic products for the treatment of cancer. Dendreon is focused on the development of therapeutic vaccines for the treatment of cancer using antigen engineering and proprietary cell separation technologies. The Company is conducting a Phase III clinical trial for Provenge(TM), its prostate cancer vaccine, and Phase II clinical trials for its multiple myeloma vaccine.